Sub-Total: $0.00
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
$0.00
Related products
-
Fr580 THE MICROBIOME AND SARS-COV-2: DAVID VERSUS A TINY GOLIATH
$0.00 Add to cart -
S551 Loss of Bifidobacteria in Lyme Disease: Cause or Effect
$0.00 Add to cart -
S227 Messenger RNA SARS-CoV-2 Vaccines Affect the Gut Microbiome
$0.00 Add to cart -
The Trespassing Bugs: Microbial Translocation Disorders
$0.00 Add to cart